“huntingtons-disease” Archives

Entry Author Date Location
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo 09/02/15 San Francisco
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
WaVe Joins the Crossover Party With $66M Series B for RNA Drugs 08/18/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
West Coast Biotech Roundup: Auspex, Hyperion, NuVasive, & More 04/02/15 San Diego
Teva Agrees to Buy San Diego’s Auspex Pharmaceuticals for $3B+ 03/30/15 San Diego
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
Auspex Shares Soar on Late-Stage Results from Huntington’s Study 12/16/14 San Diego
Neurophage Nabs $17M More to Hunt Down Brain Plaques 03/25/14 Boston
San Diego Life Sciences Roundup: Auspex, Biocept, Halozyme & More 02/07/14 San Diego
Sangamo, Biogen Team up to Make Drugs For Blood Disorders 01/09/14 San Francisco
Numerate Trains Its Drug Design Platform On Huntington’s Disease 09/24/13 San Francisco
Sangamo in Race to Replace Chronic Drug Treatment with Gene Therapies 07/15/13 San Francisco
San Diego Life Sciences Roundup: Receptos IPO, Isis, Versant, & More 04/12/13 San Diego
Roche & Isis Join Forces on Antisense Drug for Huntington’s Disease 04/08/13 San Diego
Auspex Raises $25M for Longer-Lasting, Deuterium-Based Drugs 11/08/12 San Diego
From One Japanese Backer to Another: Galenea Advances Brain Drugs 07/19/12 Boston
Xconomist of the Week: Evan Snyder—Stem Cell Reality Check 05/25/12 San Diego
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
Medivation Flunks Huntington’s Trial, Calibra Nabs Venture Cash, Open Source Biology Comes to SF, & More Bay Area Life Sciences News 04/15/11 San Francisco
Medivation, Pfizer Fail Huntington’s Test 04/11/11 San Francisco
Sangamo Partners With CHDI 04/05/11 San Francisco
Biotech Pioneer Lee Hood: Whole Families Will Get Whole Genomes Sequenced 03/10/10 Seattle
ISB Cuts Deal to Sequence 100 Genomes 11/02/09 Seattle
Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M 09/09/09 National
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News 08/06/09 San Diego
Page 1 of 2 next page »